1-50 of 107
Cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

PDCD10 promotes the tumor-supporting functions of TGF-β in pancreatic cancer

Qianwen Zhou, Katja Breitkopf-Heinlein, Haristi Gaitantzi, Emrullah Birgin, Christoph Reissfelder, Nuh N. Rahbari
Journal: Clinical Science
Clin Sci (Lond) (2024) 138 (18): 1111–1129.
https://doi.org/10.1042/CS20240450
Published: 16 September 2024
View article titled, PDCD10 promotes the tumor-supporting functions of TGF-β in pancreatic cancer
Open the PDF for PDCD10 promotes the tumor-supporting functions of TGF-β in pancreatic cancer in another window
Includes: Supplementary data
Articles

Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse model

Vincent Chiu, Christine Yee, Nathan Main, Igor Stevanovski, Matthew J Watt, Trevor Wilson, Peter Angus, Tara Roberts, Nicholas Shackel, Chandana B Chandana Herath
Journal: Clinical Science
Clin Sci (Lond) (2024) CS20240560.
https://doi.org/10.1042/CS20240560
Published: 10 September 2024
View article titled, Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse model
Open the PDF for Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse model in another window
Articles

The endothelin-1-driven tumor-stroma feed-forward loops in high-grade serous ovarian cancer

In Collection
Endothelin XVIII Conference Collection
Piera Tocci, Celia Roman, Rosanna Sestito, Valentina Caprara, Andrea Sacconi, Ivan Molineris, Giovanni Tonon, Giovanni Blandino, Anna Bagnato
Journal: Clinical Science
Clin Sci (Lond) (2024) 138 (14): 851–862.
https://doi.org/10.1042/CS20240346
Published: 05 July 2024
View article titled, The endothelin-1-driven tumor-stroma feed-forward loops in high-grade serous ovarian cancer
Open the PDF for The endothelin-1-driven tumor-stroma feed-forward loops in high-grade serous ovarian cancer in another window
Includes: Supplementary data
Articles

Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model

Tsai-Der Chuang, Nhu Ton, Nathaly Manrique, Shawn Rysling, Omid Khorram
Journal: Clinical Science
Clin Sci (Lond) (2024) 138 (12): 699–709.
https://doi.org/10.1042/CS20240190
Published: 07 June 2024
View article titled, Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model
Open the PDF for Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model in another window
Articles

Endothelin and the tumor microenvironment: a finger in every pie

In Collection
Endothelin XVIII Conference Collection
Philipp F. Arndt, Kati Turkowski, Michael J. Cekay, Bastian Eul, Friedrich Grimminger, Rajkumar Savai
Journal: Clinical Science
Clin Sci (Lond) (2024) 138 (11): 617–634.
https://doi.org/10.1042/CS20240426
Published: 24 May 2024
View article titled, Endothelin and the tumor microenvironment: a finger in every pie
Open the PDF for Endothelin and the tumor microenvironment: a finger in every pie in another window
Articles

METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner

Jianfeng Liang, Hongshi Cai, Chen Hou, Fan Song, Yaoqi Jiang, Ziyi Wang, Danqi Qiu, Yue Zhu, Fang Wang, Dongsheng Yu, Jinsong Hou
Journal: Clinical Science
Clin Sci (Lond) (2023) 137 (17): 1373–1389.
https://doi.org/10.1042/CS20230219
Published: 05 September 2023
View article titled, METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner
Open the PDF for METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner in another window
Includes: Supplementary data
Articles

Decoding the role of leptin and adiponectin in obesity-related gastrointestinal cancer

Vanda Marques, Fabiola Arella, Marta B. Afonso, André A. Santos, Cecília M.P. Rodrigues
Journal: Clinical Science
Clin Sci (Lond) (2023) 137 (15): 1095–1114.
https://doi.org/10.1042/CS20230411
Published: 02 August 2023
View article titled, Decoding the role of leptin and adiponectin in obesity-related gastrointestinal cancer
Open the PDF for Decoding the role of leptin and adiponectin in obesity-related gastrointestinal cancer in another window
Articles

M1/M2 macrophages and their overlaps – myth or reality?

Zuzana Strizova, Iva Benesova, Robin Bartolini, Rene Novysedlak, Eva Cecrdlova, Lily Koumbas Foley, Ilja Striz
Journal: Clinical Science
Clin Sci (Lond) (2023) 137 (15): 1067–1093.
https://doi.org/10.1042/CS20220531
Published: 02 August 2023
View article titled, M1/M2 macrophages and their overlaps – myth or reality?
Open the PDF for M1/M2 macrophages and their overlaps – myth or reality? in another window
Articles

Cancer and sepsis

Jeroson C. Williams, Mandy L. Ford, Craig M. Coopersmith
Journal: Clinical Science
Clin Sci (Lond) (2023) 137 (11): 881–893.
https://doi.org/10.1042/CS20220713
Published: 14 June 2023
View article titled, Cancer and sepsis
Open the PDF for Cancer and sepsis in another window
Articles

Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization

Jing-Xuan Xu, Shui-Lin Qin, Hao-Wen Wei, Yuan-Yuan Chen, Yu-Chong Peng, Lu-Nan Qi
Journal: Clinical Science
Clin Sci (Lond) (2023) 137 (4): 303–316.
https://doi.org/10.1042/CS20220661
Published: 17 February 2023
View article titled, Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization
Open the PDF for Down-regulation of ALDOB during metabolic reprogramming mediates malignant behavior in hepatocellular carcinoma and insensitivity to postoperative adjuvant transarterial chemoembolization in another window
Includes: Supplementary data
Articles

Neuregulin modulates hormone receptor levels in breast cancer through concerted action on multiple signaling pathways

Sheila Almaraz Postigo, Juan Carlos Montero
Journal: Clinical Science
Clin Sci (Lond) (2023) 137 (1): 1–15.
https://doi.org/10.1042/CS20220472
Published: 23 December 2022
View article titled, Neuregulin modulates hormone receptor levels in breast cancer through concerted action on multiple signaling pathways
Open the PDF for Neuregulin modulates hormone receptor levels in breast cancer through concerted action on multiple signaling pathways in another window
Includes: Supplementary data
Articles

CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial–mesenchymal transition via inhibiting MDM2

Xudong Wang, Yanshi Li, Min Pan, Tao Lu, Min Wang, Zhihai Wang, Chuan Liu, Guohua Hu
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (22): 1691–1710.
https://doi.org/10.1042/CS20220581
Published: 25 November 2022
View article titled, CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial–mesenchymal transition via inhibiting MDM2
Open the PDF for CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial–mesenchymal transition via inhibiting MDM2 in another window
Includes: Supplementary data
Articles

ANGPTL1, Foxo3a-Sox2, and colorectal cancer metastasis

Kai Jiang, Haiyan Chen, Kefeng Ding
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (18): 1367–1370.
https://doi.org/10.1042/CS20220394
Published: 26 September 2022
View article titled, ANGPTL1, Foxo3a-Sox2, and colorectal cancer metastasis
Open the PDF for ANGPTL1, Foxo3a-Sox2, and colorectal cancer metastasis in another window
Articles

Cellular and molecular mechanisms of breast cancer susceptibility

Sundus F. Shalabi, Mark A. LaBarge
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (13): 1025–1043.
https://doi.org/10.1042/CS20211158
Published: 04 July 2022
View article titled, Cellular and molecular mechanisms of breast cancer susceptibility
Open the PDF for Cellular and molecular mechanisms of breast cancer susceptibility in another window
Articles

Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma

Zhanzhan Li, Yanyan Li, Na Li, Liangfang Shen, Aibin Liu
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (11): 895–909.
https://doi.org/10.1042/CS20220128
Published: 06 June 2022
View article titled, Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma
Open the PDF for Silencing GOLGA8B inhibits cell invasion and metastasis by suppressing STAT3 signaling pathway in lung squamous cell carcinoma in another window
Includes: Supplementary data
Articles

Mechanisms underlying immune-related adverse events during checkpoint immunotherapy

Xiao Zhou, Xiang Chen, Leng Han, Hong Liu
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (10): 771–785.
https://doi.org/10.1042/CS20210042
Published: 27 May 2022
View article titled, Mechanisms underlying immune-related adverse events during checkpoint immunotherapy
Open the PDF for Mechanisms underlying immune-related adverse events during checkpoint immunotherapy in another window
Articles

ANGPTL1 attenuates cancer migration, invasion, and stemness through regulating FOXO3a-mediated SOX2 expression in colorectal cancer

Ting-Yu Chang, Kuo-Cheng Lan, Chen-Yuan Chiu, Meei-Ling Sheu, Shing-Hwa Liu
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (9): 657–673.
https://doi.org/10.1042/CS20220043
Published: 06 May 2022
View article titled, ANGPTL1 attenuates cancer migration, invasion, and stemness through regulating FOXO3a-mediated SOX2 expression in colorectal cancer
Open the PDF for ANGPTL1 attenuates cancer migration, invasion, and stemness through regulating FOXO3a-mediated SOX2 expression in colorectal cancer in another window
Includes: Supplementary data
Articles

Molecular mechanisms of tumour budding and its association with microenvironment in colorectal cancer

Phimmada Hatthakarnkul, Jean A. Quinn, Aula Ammar, Gerard Lynch, Hester Van Wyk, Donald C. McMillan, Chanitra Thuwajit, Joanne Edwards
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (8): 521–535.
https://doi.org/10.1042/CS20210886
Published: 21 April 2022
View article titled, Molecular mechanisms of tumour budding and its association with microenvironment in colorectal cancer
Open the PDF for Molecular mechanisms of tumour budding and its association with microenvironment in colorectal cancer in another window
Articles

Epigenomic alterations in cancer: mechanisms and therapeutic potential

Jaimie S. Gray, Sajad A. Wani, Moray J. Campbell
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (7): 473–492.
https://doi.org/10.1042/CS20210449
Published: 06 April 2022
View article titled, Epigenomic alterations in cancer: mechanisms and therapeutic potential
Open the PDF for Epigenomic alterations in cancer: mechanisms and therapeutic potential in another window
Articles

Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy

David Mas-Ponte, Marcel McCullough, Fran Supek
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (5): 383–404.
https://doi.org/10.1042/CS20210682
Published: 11 March 2022
View article titled, Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy
Open the PDF for Spectrum of DNA mismatch repair failures viewed through the lens of cancer genomics and implications for therapy in another window
Includes: Supplementary data
Articles

Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression

Natasha Kolesnikoff, Chun-Hsien Chen, Michael Susithiran Samuel
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (5): 361–377.
https://doi.org/10.1042/CS20210679
Published: 09 March 2022
View article titled, Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression
Open the PDF for Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression in another window
Articles

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer

Richard Cunningham, Carsten Gram Hansen
Journal: Clinical Science
Clin Sci (Lond) (2022) 136 (3): 197–222.
https://doi.org/10.1042/CS20201474
Published: 04 February 2022
View article titled, The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Open the PDF for The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer in another window
Articles

Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity

In Collection
Cardiovascular-Oncology
Ninian N. Lang, Rhian M. Touyz
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (23): 2661–2663.
https://doi.org/10.1042/CS20210986
Published: 09 December 2021
View article titled, Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity
Open the PDF for Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity in another window
Articles

A novel epigenetic drug conjugating flavonoid and HDAC inhibitor confer suppression of acute myeloid leukemogenesis

Juan Zhang, Xuefeng Gao, Mingming Wei, Yonghui Li, Guang Yang, Cheng Yang, Li Yu
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (14): 1751–1765.
https://doi.org/10.1042/CS20210571
Published: 27 July 2021
View article titled, A novel epigenetic drug conjugating flavonoid and HDAC inhibitor confer suppression of acute myeloid leukemogenesis
Open the PDF for A novel epigenetic drug conjugating flavonoid and HDAC inhibitor confer suppression of acute myeloid leukemogenesis in another window
Includes: Supplementary data
Articles

The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension

In Collection
Cardiovascular-Oncology
Daniel N. Meijles, Joshua J. Cull, Susanna T.E. Cooper, Thomais Markou, Michelle A. Hardyman, Stephen J. Fuller, Hajed O. Alharbi, Zoe H.R. Haines, Viridiana Alcantara-Alonso, Peter E. Glennon, Mary N. Sheppard, Peter H. Sugden, Angela Clerk
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (14): 1631–1647.
https://doi.org/10.1042/CS20210192
Published: 23 July 2021
View article titled, The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension
Open the PDF for The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension in another window
Includes: Supplementary data
Articles

Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?

In Collection
Cardiovascular-Oncology
Daan C.H. van Dorst, Leni van Doorn, Katrina M. Mirabito Colafella, Olivier C. Manintveld, H. Carlijne Hassing, A.H. Jan Danser, Ron H.J. Mathijssen, Jorie Versmissen
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (14): 1649–1668.
https://doi.org/10.1042/CS20200300
Published: 20 July 2021
View article titled, Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?
Open the PDF for Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk? in another window
Articles

Unravelling the tangled web of hypertension and cancer

In Collection
Cardiovascular-Oncology
Aristeidis Sionakidis, Linsay McCallum, Sandosh Padmanabhan
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (13): 1609–1625.
https://doi.org/10.1042/CS20200307
Published: 09 July 2021
View article titled, Unravelling the tangled web of hypertension and cancer
Open the PDF for Unravelling the tangled web of hypertension and cancer in another window
Articles

Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents

David L. Brautigan, Caroline Farrington, Goutham Narla
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (13): 1545–1556.
https://doi.org/10.1042/CS20201367
Published: 30 June 2021
View article titled, Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents
Open the PDF for Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents in another window
Articles

Interactions between cardiology and oncology drugs in precision cardio-oncology

In Collection
Cardiovascular-Oncology
Sailaja Kamaraju, Meera Mohan, Svetlana Zaharova, Brianna Wallace, Joseph McGraw, James Lokken, John Tierney, Elizabeth Weil, Olubadewa Fatunde, Sherry-Ann Brown
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (11): 1333–1351.
https://doi.org/10.1042/CS20200309
Published: 02 June 2021
View article titled, Interactions between cardiology and oncology drugs in precision cardio-oncology
Open the PDF for Interactions between cardiology and oncology drugs in precision cardio-oncology in another window
Articles

Missing links — epigenetic regulators of the pancreatic cancer–associated inflammation

Gregor Werba, Tamas A. Gonda
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (10): 1289–1293.
https://doi.org/10.1042/CS20210181
Published: 28 May 2021
View article titled, Missing links — epigenetic regulators of the pancreatic cancer–associated inflammation
Open the PDF for Missing links — epigenetic regulators of the pancreatic cancer–associated inflammation in another window
Articles

Emerging role of carbonic anhydrase inhibitors

Claudiu T. Supuran
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (10): 1233–1249.
https://doi.org/10.1042/CS20210040
Published: 20 May 2021
View article titled, Emerging role of carbonic anhydrase inhibitors
Open the PDF for Emerging role of carbonic anhydrase inhibitors in another window
Articles

In utero and early-life exposure to thirdhand smoke causes profound changes to the immune system

Antoine M. Snijders, Mi Zhou, Todd P. Whitehead, Briana Fitch, Priyatama Pandey, Aaron Hechmer, Abel Huang, Suzaynn F. Schick, Adam J. de Smith, Adam B. Olshen, Catherine Metayer, Jian-Hua Mao, Joseph L. Wiemels, Scott C. Kogan
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (8): 1053–1063.
https://doi.org/10.1042/CS20201498
Published: 23 April 2021
View article titled, In utero and early-life exposure to thirdhand smoke causes profound changes to the immune system
Open the PDF for In utero and early-life exposure to thirdhand smoke causes profound changes to the immune system in another window
Includes: Supplementary data
Articles

Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure

In Collection
Cardiovascular-Oncology
Leanne Mooney, Carl S. Goodyear, Tamir Chandra, Kristina Kirschner, Mhairi Copland, Mark C. Petrie, Ninian N. Lang
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (7): 991–1007.
https://doi.org/10.1042/CS20200306
Published: 16 April 2021
View article titled, Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure
Open the PDF for Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure in another window
Articles

EB2 promotes hepatocellular carcinoma proliferation and metastasis via MAPK/ERK pathway by modulating microtubule dynamics

Fang-Jing Zhong, Yi-Ming Li, Cong Xu, Bo Sun, Ji-Long Wang, Lian-Yue Yang
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (7): 847–864.
https://doi.org/10.1042/CS20201500
Published: 06 April 2021
View article titled, EB2 promotes hepatocellular carcinoma proliferation and metastasis via MAPK/ERK pathway by modulating microtubule dynamics
Open the PDF for EB2 promotes hepatocellular carcinoma proliferation and metastasis via MAPK/ERK pathway by modulating microtubule dynamics in another window
Includes: Supplementary data
Articles

KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages

Mu-xing Li, Hang-yan Wang, Chun-hui Yuan, Zhao-lai Ma, Bin Jiang, Lei Li, Li Zhang, Dian-rong Xiu
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (4): 629–649.
https://doi.org/10.1042/CS20201259
Published: 22 February 2021
View article titled, KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages
Open the PDF for KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages in another window
Includes: Supplementary data
Articles

P2X7 receptor antagonism increases regulatory T cells and reduces clinical and histological graft-versus-host disease in a humanised mouse model

Peter Cuthbertson, Nicholas J. Geraghty, Sam R. Adhikary, Sienna Casolin, Debbie Watson, Ronald Sluyter
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (3): 495–513.
https://doi.org/10.1042/CS20201352
Published: 03 February 2021
View article titled, P2X7 receptor antagonism increases regulatory T cells and reduces clinical and histological graft-versus-host disease in a humanised mouse model
Open the PDF for P2X7 receptor antagonism increases regulatory T cells and reduces clinical and histological graft-versus-host disease in a humanised mouse model in another window
Includes: Supplementary data
Articles

The long noncoding RNA KTN1-AS1 promotes bladder cancer tumorigenesis via KTN1 cis -activation and the consequent initiation of Rho GTPase-mediated signaling

Xueying Hu, Liang Xiang, Dong He, Rongrong Zhu, Jianing Fang, Zhanwang Wang, Ke Cao
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (3): 555–574.
https://doi.org/10.1042/CS20200908
Published: 03 February 2021
View article titled, The long noncoding RNA KTN1-AS1 promotes bladder cancer tumorigenesis via KTN1 cis -activation and the consequent initiation of Rho GTPase-mediated signaling
Open the PDF for The long noncoding RNA KTN1-AS1 promotes bladder cancer tumorigenesis via KTN1 cis -activation and the consequent initiation of Rho GTPase-mediated signaling in another window
Includes: Supplementary data
Articles

Cardiotoxic effects of angiogenesis inhibitors

In Collection
Cardiovascular-Oncology
Stephen J.H. Dobbin, Mark C. Petrie, Rachel C. Myles, Rhian M. Touyz, Ninian N. Lang
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (1): 71–100.
https://doi.org/10.1042/CS20200305
Published: 06 January 2021
View article titled, Cardiotoxic effects of angiogenesis inhibitors
Open the PDF for Cardiotoxic effects of angiogenesis inhibitors in another window
Articles

Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression

Jitske van den Bulk, Noel F.C.C. de Miranda, Peter ten Dijke
Journal: Clinical Science
Clin Sci (Lond) (2021) 135 (1): 35–52.
https://doi.org/10.1042/CS20201236
Published: 05 January 2021
View article titled, Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
Open the PDF for Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression in another window
Articles

Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia

Erna Yang, Wei Guan, Desheng Gong, Xuefeng Gao, Caixia Han, Juan Zhang, Hong Wang, Mengzhen Wang, Yonghui Li, Li Yu
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (23): 3079–3091.
https://doi.org/10.1042/CS20200786
Published: 02 December 2020
View article titled, Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia
Open the PDF for Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia in another window
Includes: Supplementary data
Articles

CYP1B1 as a therapeutic target in cardio-oncology

In Collection
Cardiovascular-Oncology
Alexa N. Carrera, Marianne K.O. Grant, Beshay N. Zordoky
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (21): 2897–2927.
https://doi.org/10.1042/CS20200310
Published: 13 November 2020
View article titled, CYP1B1 as a therapeutic target in cardio-oncology
Open the PDF for CYP1B1 as a therapeutic target in cardio-oncology in another window
Articles

Cardiovascular toxicity of PI3Kα inhibitors

In Collection
Cardiovascular-Oncology
Chandu Sadasivan, Pavel Zhabyeyev, Dina Labib, James A. White, D. Ian Paterson, Gavin Y. Oudit
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (19): 2595–2622.
https://doi.org/10.1042/CS20200302
Published: 14 October 2020
View article titled, Cardiovascular toxicity of PI3Kα inhibitors
Open the PDF for Cardiovascular toxicity of PI3Kα inhibitors in another window
Articles

Vascular toxicity associated with anti-angiogenic drugs

In Collection
Cardiovascular-Oncology
Karla B. Neves, Augusto C. Montezano, Ninian N. Lang, Rhian M. Touyz
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (18): 2503–2520.
https://doi.org/10.1042/CS20200308
Published: 29 September 2020
View article titled, Vascular toxicity associated with anti-angiogenic drugs
Open the PDF for Vascular toxicity associated with anti-angiogenic drugs in another window
Articles

Emerging roles for the IL-6 family of cytokines in pancreatic cancer

Gemma van Duijneveldt, Michael D.W. Griffin, Tracy L. Putoczki
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (16): 2091–2115.
https://doi.org/10.1042/CS20191211
Published: 18 August 2020
View article titled, Emerging roles for the IL-6 family of cytokines in pancreatic cancer
Open the PDF for Emerging roles for the IL-6 family of cytokines in pancreatic cancer in another window
Articles

RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer

Huaiming Wang, Rongkang Huang, Wentai Guo, Xiusen Qin, Zifeng Yang, Zixu Yuan, Yingqi Wei, Chunlin Mo, Zhantao Zeng, Jian Luo, Jian Cai, Hui Wang
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (14): 1973–1990.
https://doi.org/10.1042/CS20191174
Published: 28 July 2020
View article titled, RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer
Open the PDF for RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer in another window
Includes: Supplementary data
Articles

Circular RNA circFGD4 suppresses gastric cancer progression via modulating miR-532-3p/APC/β-catenin signalling pathway

Xinglong Dai, Jianjun Liu, Xiong Guo, Anqi Cheng, Xiaoya Deng, Liqun Guo, Ziwei Wang
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (13): 1821–1839.
https://doi.org/10.1042/CS20191043
Published: 17 July 2020
View article titled, Circular RNA circFGD4 suppresses gastric cancer progression via modulating miR-532-3p/APC/β-catenin signalling pathway
Open the PDF for Circular RNA circFGD4 suppresses gastric cancer progression via modulating miR-532-3p/APC/β-catenin signalling pathway in another window
Articles

Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway

Yongjie Zhou, Qing Xu, Lv Tao, Yuwei Chen, Yuke Shu, Zhenru Wu, Changli Lu, Yujun Shi, Hong Bu
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (12): 1457–1472.
https://doi.org/10.1042/CS20200244
Published: 18 June 2020
View article titled, Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway
Open the PDF for Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway in another window
Includes: Supplementary data
Articles

p110δ PI3K as a therapeutic target of solid tumours

Lydia Xenou, Evangelia A. Papakonstanti
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (12): 1377–1397.
https://doi.org/10.1042/CS20190772
Published: 18 June 2020
View article titled, p110δ PI3K as a therapeutic target of solid tumours
Open the PDF for p110δ PI3K as a therapeutic target of solid tumours in another window
Articles

LOC101928834, a novel lncRNA in Wnt/β-catenin signaling pathway, promotes cell proliferation and predicts poor clinical outcome in myelodysplastic syndromes

Nianyi Li, Yan Ma, Wei Wang, C. Cameron Yin, Wanling Wu, Ruichen Sun, Guangjie Zhao, Shuang Li, Xiaoqin Wang
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (11): 1279–1293.
https://doi.org/10.1042/CS20200439
Published: 15 June 2020
View article titled, LOC101928834, a novel lncRNA in Wnt/β-catenin signaling pathway, promotes cell proliferation and predicts poor clinical outcome in myelodysplastic syndromes
Open the PDF for LOC101928834, a novel lncRNA in Wnt/β-catenin signaling pathway, promotes cell proliferation and predicts poor clinical outcome in myelodysplastic syndromes in another window
Includes: Supplementary data
Articles

Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesis

Valentina Vaira, Gabriella Gaudioso, Maria Antonella Laginestra, Andrea Terrasi, Claudio Agostinelli, Silvano Bosari, Antonio Di Sabatino, Alessandro Vanoli, Marco Paulli, Stefano Ferrero, Leda Roncoroni, Vincenza Lombardo, Liyanage P. Perera, Sonia Fabris, Maurizio Vecchi, Stefano Pileri, Luca Elli
Journal: Clinical Science
Clin Sci (Lond) (2020) 134 (10): 1151–1166.
https://doi.org/10.1042/CS20200032
Published: 22 May 2020
View article titled, Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesis
Open the PDF for Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesis in another window
Includes: Supplementary data